Efficacy and safety of nivolumab for previously treated non-squamous cell carcinoma of the head and neck

被引：0
|
作者：
Suzuki, Chiaki [1 ]
Kiyota, Naomi [1 ,2 ]
Imamura, Yoshinori [1 ]
Rikitake, Junpei [1 ]
Sai, Satoshi [1 ]
Kimbara, Shiro [1 ]
Hyogo, Yasuko [1 ]
Nagatani, Yoshiaki [1 ]
Funakoshi, Yohei [1 ]
Toyoda, Masanori [1 ]
Minami, Hironobu [1 ]
机构：
[1] Kobe Univ Hosp, Dept Med Oncol Hematol, Kobe, Hyogo, Japan
[2] Kobe Univ Hosp, Canc Ctr, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1 - 008
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [2] Efficacy of chemotherapy after progression with nivolumab in squamous cell carcinoma of the head and neck
    Suzuki, Shinsuke
    Toyoma, Satoshi
    Tomizawa, Hiroki
    Yamada, Toshiki
    Iikawa, Nobuko
    Shiina, Kazuhiro
    Saito, Hidekazu
    Koizumi, Koh
    Kawasaki, Yohei
    Yamada, Takechiyo
    [J]. AURIS NASUS LARYNX, 2020, 47 (03) : 485 - 488
  • [3] Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
    Nishikawa, Daisuke
    Suzuki, Hidenori
    Beppu, Shintaro
    Terada, Hoshino
    Sawabe, Michi
    Kadowaki, Shigenori
    Sone, Michihiko
    Hanai, Nobuhiro
    [J]. CANCER SCIENCE, 2021, 112 (01) : 339 - 346
  • [4] Antibiotics may interfere with nivolumab efficacy in patients with head and neck squamous cell carcinoma
    Ueta, Reio
    Imai, Hiroo
    Saijo, Ken
    Kawamura, Yoshifumi
    Kodera, Shuto
    Komine, Keigo
    Ouchi, Kota
    Kasahara, Yuki
    Taniguchi, Sakura
    Yoshida, Yuya
    Sasaki, Keiju
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    [J]. ONCOLOGY, 2024, 102 (03) : 252 - 259
  • [5] Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small Cell Lung Cancer
    Wu, Feng Ying
    Zhang, Shi Jia
    Ren, Sheng Xiang
    Zhou, Caicun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1286 - S1287
  • [6] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1856 - 1867
  • [7] Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
    Ben Rothwell
    Christopher Kiff
    Caroline Ling
    Thor-Henrik Brodtkorb
    [J]. PharmacoEconomics - Open, 2021, 5 : 251 - 260
  • [8] Nivolumab for recurrent squamous-cell carcinoma of the head and neck
    [J]. British Dental Journal, 2016, 221 (10) : 632 - 632
  • [9] Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity
    Iwata, Hiromitsu
    Toshito, Toshiyuki
    Hayashi, Kensuke
    Yamada, Maho
    Omachi, Chihiro
    Nakajima, Koichiro
    Hattori, Yukiko
    Hashimoto, Shingo
    Kuroda, Yo
    Okumura, Yoshihide
    Mizoe, Jun-etsu
    Ogino, Hiroyuki
    Shibamoto, Yuta
    [J]. JOURNAL OF RADIATION RESEARCH, 2019, 60 (05) : 612 - 621
  • [10] Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
    Rothwell, Ben
    Kiff, Christopher
    Ling, Caroline
    Brodtkorb, Thor-Henrik
    [J]. PHARMACOECONOMICS-OPEN, 2021, 5 (02) : 251 - 260
12345